Lilly Iskold is an Analyst at 2048 Ventures, with prior research experience at Humane Genomics and the New York Genome Center. She holds a B.A. in Biology from Brandeis University.
At firms with a similar stage, sector and check size.
One email when Lilly's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckLilly Iskold is an Analyst at 2048 Ventures, with prior research experience at Humane Genomics and the New York Genome Center. She holds a B.A. in Biology from Brandeis University.
Lilly Iskold invests through 2048 Ventures, which writes checks of $500K to $3M at pre-seed.
A warm intro from a founder 2048 Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.
Humane Genomics; New York Genome Center; research experience at Humane Genomics; research experience at New York Genome Center.
Last updated 2026-10-15. Is this you? Ask for a correction.